Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)-Reference-Cited by-同舟云学术

Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

Published:2024-05-15 Issue:6 Volume:14 Page:1649-1657
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Valenti Mario^ORCID,Gargiulo Luigi,Ibba Luciano,Malagoli Piergiorgio,Amoruso Fabrizio,Balato Anna,Bardazzi Federico,Burlando Martina,Carrera Carlo G.,Dapavo Paolo,Dini Valentina,Gaiani Francesca M.,Girolomoni Giampiero,Guarneri Claudio,Lasagni Claudia,Loconsole Francesco,Marzano Angelo V.,Maurelli Martina,Megna Matteo,Orsini Diego,Travaglini Massimo,Costanzo Antonio,Narcisi Alessandra

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13555-024-01182-4.pdf

Reference14 articles.

1. Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–94. https://doi.org/10.1016/S0140-6736(14)61909-7.

2. Dave R, Alkeswani A. An overview of biologics for psoriasis. J Drugs Dermatol. 2021;20(11):1246–7. https://doi.org/10.36849/jdd.6040.

3. European Medicines Agency. Taltz (ixekizumab): summary of product characteristics. 2019. https://www.ema.europa.eu/en/medicines/human/EPAR/taltz. Accessed 15 Mar 2024.

4. Leonardi C, Reich K, Foley P, et al. Efficacy and safety of ixekizumab through 5 years in moderate-to-severe psoriasis: long-term results from the UNCOVER-1 and UNCOVER-2 phase-3 randomized controlled trials. Dermatol Ther (Heidelb). 2020;10(3):431–47. https://doi.org/10.1007/s13555-020-00367-x.

5. Blauvelt A, Lebwohl MG, Mabuchi T, et al. Long-term efficacy and safety of ixekizumab: a 5-year analysis of the UNCOVER-3 randomized controlled trial. J Am Acad Dermatol. 2021;85(2):360–8. https://doi.org/10.1016/j.jaad.2020.11.022.